Publication date context for this report is February 11 2026 and the focus is a home based hypertension study using the ENHANCe app that requires invitation.
A home monitored assessment trial uses the ENHANCe app as the device component, with teaching and training and usual care included in the intervention. Sponsors are SingHealth Polyclinics and Nanyang Polytechnic. Enrollment is by invitation, and the ClinicalTrials.gov entry is NCT07399912.
What is the ENHANCe app and what does this trial seek to achieve?
The ENHANCe app is the device component described in the study summary for hypertension management in a home setting. The intervention combines device use with teaching and training and usual care to support decision making in clinical encounters. Sponsorship is listed by SingHealth Polyclinics and Nanyang Polytechnic, and enrollment is by invitation.
Intended use and regulatory context
The source describes a device based approach to support home based assessment in hypertension. The description implies use by patients in their homes along with clinician input. The materials reference teaching and training as part of the intervention and include usual care. The sponsor names appear and enrollment is described as by invitation, reinforcing a controlled study design for evaluation.
How does the home monitoring work?
Details are limited to the combination of device use and education within usual care as part of a registered trial.
Trial details and enrollment status
The trial involves a device called ENHANCe app as part of a home based assessment protocol for hypertension. Teaching and training are included, together with usual care. Sponsorship is credited to SingHealth Polyclinics and Nanyang Polytechnic. Enrolling by invitation indicates selective participant recruitment.
Safety and performance considerations from a regulatory perspective
From a regulatory perspective the description implies that the ENHANCe app serves to support home based assessment for hypertension management. The document would define the intended purpose, performance and safety requirements. Any statements attributed to the manufacturer would be labeled as such in accordance with MDR style.
External source link
The ClinicalTrials.gov entry for this study provides official registration details. External link: NCT07399912 ClinicalTrials.gov entry.
Frequently asked questions
- 1. What is the ENHANCe app used for?
The ENHANCe app is described as the device component used in a home based hypertension assessment protocol to support clinical decision making. - 2. Who can participate?
Enrollment is described as by invitation, implying selective participation in a controlled study. - 3. What is included in the intervention?
The intervention includes device use with teaching and training and usual care as described in the study summary. - 4. Who sponsors the study?
Sponsorship is listed to SingHealth Polyclinics and Nanyang Polytechnic. - 5. Where can I find official registration details?
Official details are on ClinicalTrials.gov under NCT07399912.
Conclusion and implications
The information outlines a home based assessment approach for hypertension that uses a device and education as part of a clinical study. Regulators and clinicians should monitor the evolving regulatory documentation and any safety assessments that accompany home based digital health tools.
Disclaimer
This article is for professionals and reflects regulatory style. It is not legal advice.
Announcement line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07399912?term=medical+device